Quantitative Concept – Page 33

LGBTQ+ Populations Face Higher Cancer Risk Due to Barriers to Healthcare

11 months ago talkbio0Tagged barriers, Cancer Risk, Discrimination (process of differentiation), Health care facility, LGBTQ+, Minority Groups, Stress

LGBTQ+, cancer risk, barriers to healthcare, American Cancer Society, discrimination, minority stress

BMS Details Confirmatory Trial Win for KRAS Inhibitor Krazati

11 months ago talkbio0Tagged Accelerated, Approved, Confirmatory Trial, Inhibitor, K-ras Oncogene, KRAZATI, Myers, Non-Small Cell Lung Carcinoma, Pharmacotherapy, Progression-Free Survival, squibb, United States Food and Drug Administration

Bristol Myers Squibb, Krazati, KRAS inhibitor, confirmatory trial, non-small cell lung cancer (NSCLC), progression-free survival (PFS), chemotherapy, accelerated approval, FDA

Gilead’s Trodelvy Fails to Meet Primary Endpoint in Confirmatory Trial for Urothelial Cancer

11 months ago talkbio0Tagged Antibody-Drug Conjugates, Approved, Clinical Trials, Gilead Sciences, Neoplasms, Overall Survival, Trodelvy, TROPiCS-04 study, United States Food and Drug Administration, urothelial cancer

Gilead Sciences, Trodelvy, urothelial cancer, TROPiCS-04 study, overall survival, antibody-drug conjugate, oncology, clinical trials, FDA approval

Galapagos Partners with Adaptimmune for $665M T-Cell Therapy Collaboration

11 months ago talkbio0Tagged Adaptimmune, biobucks, Collaboration, financing characteristics, Galapagos, Licensing, Melanoma-Associated Antigen 4, next-generation therapy, T-Cell Receptor, T-cell therapy

Galapagos, Adaptimmune, T-cell therapy, MAGE-A4 TCR, Uza-cel, Biobucks collaboration, Licensing deal, Financing, Next-generation therapy

NS Pharma’s Duchenne Muscular Dystrophy Therapy Viltepso Fails Confirmatory Trial

11 months ago talkbio0Tagged Approved, Clinical Research, Confirmatory Trial, Duchenne, Muscular Dystrophy, nanosecond, Pharma, Phase III, RACER53, United States Food and Drug Administration, Viltepso

NS Pharma, Viltepso, Duchenne Muscular Dystrophy, Confirmatory Trial, Phase III, RACER53 Study, FDA Approval

NS Pharma’s Viltepso Fails Confirmatory Phase III Trial for Duchenne Muscular Dystrophy Treatment

11 months ago talkbio0Tagged Approved, Clinical Research, Confirmatory Trial, Muscular Dystrophy, Duchenne, nanosecond, Pharma, Phase 3 Clinical Trials, RACER53, United States Food and Drug Administration, Viltepso

Viltepso, NS Pharma, Duchenne muscular dystrophy, RACER53 study, viltolarsen, FDA approval, confirmatory trial, phase III trial, DMD treatment

Ozempic Reduces Mortality Risk by 20% in Diabetes Patients with Chronic Kidney Disease

11 months ago11 months ago talkbio0Tagged Cardiovascular system, Cessation of life, Chronic Kidney Diseases, Diabetes, Failure (biologic function), Kidney, Mortality Vital Statistics, Nordisk, Obesity, semaglutide, Wegovy

** Ozempic, Novo Nordisk, diabetes, chronic kidney disease, mortality risk, cardiovascular deaths, kidney failure, semaglutide, Wegovy, obesity treatment

Minimal Weight Reduction Observed with Low Doses of New Zealand’s GLP-1/GLP-2 Agonist

11 months ago talkbio0Tagged Agonist, Body Weight, Dosage, Effect, GLP-1/GLP-2, Lowest, Minimal, New Zealand

New Zealand, GLP-1/GLP-2 agonist, weight reduction, lowest doses, minimal effect.

Semaglutide Significantly Improves Cardiovascular Health and Reduces Mortality Risk in Kidney Disease Patients, Novo Reports

11 months ago talkbio0Tagged Cardiovascular system, Clinical Trials, Health, Mortality Vital Statistics, Novo, semaglutide

Semaglutide, Novo, cardiovascular health, kidney disease, mortality risk, clinical trial

Revolutionizing Biotherapeutic Analysis: Novel icIEF Fractionation and Mass Spectrometry for Charge Characterization

11 months ago talkbio0Tagged analytical techniques, Biological Factors, biotherapeutics, Characterization, charge amounts, Chemical fractionation, Imaged Capillary Isoelectric Focusing, Protein Analysis, protein charge, Protein Purification, protein separation, therapeutic protein, Variant

biotherapeutics, icIEF fractionation, mass spectrometry, charge characterization, protein analysis, therapeutic proteins, biopharmaceuticals, analytical techniques, protein purification, protein separation, protein charge variants.